scispace - formally typeset
F

Florence Demenais

Researcher at French Institute of Health and Medical Research

Publications -  228
Citations -  14269

Florence Demenais is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Genome-wide association study & Population. The author has an hindex of 58, co-authored 225 publications receiving 13069 citations. Previous affiliations of Florence Demenais include Institut Gustave Roussy & Foundation Center.

Papers
More filters
Journal ArticleDOI

Méthodes statistiques pour identifier les gènes dans les maladies multifactorielles

Florence Demenais, +2 more
- 01 Jan 1996 - 
TL;DR: In this paper, des methodologies statistiques permettent de mettre en evidence les facteurs de susceptibilite genetique, d'elucider leurs mecanismes d'action and leurs interactions avec les factes de milieu dans l'etiologie de ces pathologies complexes.
Journal ArticleDOI

A linkage study of HLA and maturity onset type diabetes of the young (MODY)

Ingeborg Deschamps, +5 more
- 11 Dec 2008 - 
TL;DR: Linkage analysis was performed between HLA and Maturity-Onset Type Diabetes of the Young (MODY) in 9 families and no significant positive lod scores were found.
Journal ArticleDOI

Exclusion of a tight linkage between familial polyposis coli and HLA

C. Raffoux, +4 more
- 11 Dec 2008 - 
TL;DR: Linkage studies with various markers should be pursued to permit detection of high risk individuals and to better understand the phenotypic variability observed in certain polyposis families.
Journal ArticleDOI

Germ-line mutations in p16 and CDK4 genes in 38 melanoma families: 459

Paillerets Brigitte Bressac-de, +6 more
- 01 Jun 1997 - 
Journal ArticleDOI

4th Pediatric Allergy and Asthma Meeting (PAAM)

S. Tolga Yavuz, +931 more
- 21 Nov 2016 - 
TL;DR: Previous exacerbation is the most important risk factor for future exacerbations in school-age children with asthma and chemical modification of a peanut extract results in an increased safety profile while maintaining efficacy.